- Global Pharma News & Resources

Non-Hormonal Steroid Modulators Market Look a Witness of Excellent Long-Term Growth – Worldwide Survey by 2031

The global non-hormonal steroid modulators market is exhibiting steady growth and the trend is expected to continue for the forecast period between 2021 and 2031.

According to World Health Organization (WHO), 1 in every 3000 individuals is affected with muscular dystrophy. Besides this, the prevalence of arthritis varies between 0.3% and 1% people. Studies have shown that women are more vulnerable compared to males. Thus, the demand for non-hormonal steroid modulators treatment to curb the incidence of arthritis creates significant opportunities for the market.

As per a study by World Health Organization (WHO), in the year 2020, around 10 million deaths were reported due to cancer. Furthermore, near about 13% of cancers diagnosed in 2018 were attributed to carcinogenic infections across the globe. As non-hormonal steroid modulators such as RU49953 play an important role in treating cancer drug resistance, the demand for non-hormonal steroid modulators is expected to soar. 

Request For A Brochure :

Competitive Landscape 

Reveragen Biopharma inc is a leading player in the market. It has increased its focus on developing novel non-hormonal steroid modulators for expanding their portfolio and strategic collaboration with other companies. For instance,

  • In 2020, ReveraGen, Inc., introduced vamorolone (VBP15) as a safer alternative for corticosteroid treatment in Duchenne muscular dystrophy and other disorders. The company received an award of a $3.3 million from the National Institute of Neurological Disorders and Stroke (NINDS) at National Institutes of Health (NIH) for the development of novel modulators
  • ReveraGen has made collaboration with Santhera for the commercialization of novel vamorolone.

More Insights on the Non-Hormonal Steroid Modulators Market

In its latest report, Fact.MR offers an unbiased analysis of the non-hormonal steroid modulators market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of modulator type (RU49953, and non-hormonal steroid NF-κB modulator), indication (arthritis, muscular dystrophy, and cancer drug-resistance), and across seven regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa). 

Non-Hormonal Steroid Modulators Market: Segmentation

The global non-hormonal steroid modulators are segmented into by modulator type, indication and region. 

By modulator type, the global non-hormonal steroid modulators are further segmented into:

  • RU49953
  • Non-Hormonal Steroid NF-κB Modulator

By indication, the global non-hormonal steroid modulators are further segmented into:

  • Arthritis
  • Muscular Dystrophy
  • Cancer Drug-Resistance (Drug Efflux)

Share Your Requirements & Get Customized Reports :

Non-Hormonal Steroid Modulators Market: Regional Outlook

Europe dominates the global non-hormonal steroid modulators market with its leading research studies and clinical trials, the European market is pushed by the high prevalence of arthritis in this region, and special attention of European Commission towards muscular dystrophy therapies. North America holds the second-largest non-hormonal steroid modulators market with its active R&D activities, key players and non-hormonal steroid modulators patent claimed for muscular dystrophy and arthritis.

Asia-Pacific non-hormonal steroid modulators are expected to bloom in future, with the massive burden of arthritis, escalating research and improving healthcare, along with the support of government funding. Latin America non-hormonal steroid modulator market is expected to grow moderately with improving research and healthcare. The Middle East & Africa non-hormonal steroid modulators market is expected to remain stagnant due to the under-developed medical healthcare and R&D infrastructure.

Latin America is expected to grow at a moderate rate with the gradual elevation of the research and technology. The Middle East & Africa is expected to have a stagnant growth due to the under-developed research infrastructure.

Read More Trending and Similar Reports from Fact.MR –

Explore Fact.MR’s Coverage on the Healthcare Domain

Oral & Topical Anesthetics market: Fact.MR recently published a market study on the global oral & topical anesthetics market. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities, and restraints, as well as detailed information about the market structure.

Alexandrite Gemstone Lasers Market: Fact. MR’s extensive coverage on alexandrite gemstone lasers market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future.

Dermatology Devices Market: Fact.MR gives a detailed assessment of dermatology devices market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Editor Details

Last Updated: 23-Aug-2021